Normal skeletal muscle Na+-K+ pump concentration in patients with chronic heart failure

Intrinsic changes in skeletal muscle are being increasingly suspected as part of the underlying cause of exercise intolerance in patients with chronic heart failure (CHF). The objective of the present study was to determine whether differences existed between CHF patients and age‐matched healthy con...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Muscle & nerve 2001-01, Vol.24 (1), p.69-76
Hauptverfasser: Green, H.J., Duscha, B.D., Sullivan, M.J., Keteyian, S.J., Kraus, W.E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 76
container_issue 1
container_start_page 69
container_title Muscle & nerve
container_volume 24
creator Green, H.J.
Duscha, B.D.
Sullivan, M.J.
Keteyian, S.J.
Kraus, W.E.
description Intrinsic changes in skeletal muscle are being increasingly suspected as part of the underlying cause of exercise intolerance in patients with chronic heart failure (CHF). The objective of the present study was to determine whether differences existed between CHF patients and age‐matched healthy controls in the concentration of skeletal muscle Na+‐K+–ATPase (adenosine triphosphatase), a cation pump that functions to restore Na+‐K+ gradients and protect membrane excitability. Moreover, given the potency for physical activity in altering long‐term regulation of the pump, an additional objective was to examine the role of activity level in pump expression in CHF patients. Na+‐K+–ATPase concentration (pmol/g wet wt) determined in the vastus lateralis muscle of 27 CHF males (ejection fraction, 23 ± 1.6%), using the vanadate facilitated [3H] ouabain binding technique, was not different (264 ± 10) from 10 sedentary controls (268 ± 19,P > 0.05). Similarly, no differences (P > 0.05) could be found between female patients (228 ± 16, n = 7) and controls (243 ± 13, n = 9). Differences between untrained control (294 ± 20, n = 7), chronically active (251 ± 20, n = 9), and trained (252 ± 16, n = 6) CHF groups in Na+‐K+ pump expression were also insignificant. This study indicates that long‐term regulation of Na+‐K+–ATPase concentration is not altered in moderate CHF patients, regardless of the history of regular activity. However, the positive correlations (P < 0.05) that were observed between peak aerobic power (V̇O2 peak) and Na+‐K+–ATPase (r = 0.422) and V̇O2 peak and maximal citrate synthase activity (r = 0.404) suggests a role for the skeletal muscle in explaining exercise intolerance in CHF patients. © 2001 John Wiley & Sons, Inc. Muscle Nerve 24: 69–76, 2001
doi_str_mv 10.1002/1097-4598(200101)24:1<69::AID-MUS8>3.0.CO;2-O
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70573048</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70573048</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4148-90349782492eceac1a55a75be7c8c1814688382f827e1e3878eff3848af75ffe3</originalsourceid><addsrcrecordid>eNqNkF1rFDEUQAdR7Lb6F2RAEKXMmq-ZZFYRyqq1uN0Ba7d9u6Txhh07X01mqP33ZpxlffHBp9yEw8nlRFFKyZwSwt5SkstEpLl6zQihhL5hYkHfZ_licXL2MTm_vFAf-JzMl8U7lhSPotmefxzNCBUqyXh-fRAdev-TBIHK5NPogFKakjxTs-hq3bpaV7G_xQr7MNSDNxXGa32cfD2Ou6HuYtM2Bpve6b5sm7hs4i5M4cHH92W_jc3WtU1p4i1q18dWl9Xg8Fn0xOrK4_PdeRRdfv70ffklWRWnZ8uTVWLEuFxOuMilYiJnaFAbqtNUy_QGpVGGKioypbhiVjGJFLmSCq3lSihtZWot8qPo1eTtXHs3oO-hLr3BqtINtoMHSVLJiVABPJ9A41rvHVroXFlr9wCUwFgaxnIwloOpNDABFLIcIJSGsTRwILAsgEERfC92Hw83Nf74a9ulDcDLHaC90ZV1ujGl33N5ljHBA7WeqPuywof_3-kfK_25B2EyCUvf46-9ULtbyCSXKVytT2F1wb5tNptryPhv5IWxFA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70573048</pqid></control><display><type>article</type><title>Normal skeletal muscle Na+-K+ pump concentration in patients with chronic heart failure</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Green, H.J. ; Duscha, B.D. ; Sullivan, M.J. ; Keteyian, S.J. ; Kraus, W.E.</creator><creatorcontrib>Green, H.J. ; Duscha, B.D. ; Sullivan, M.J. ; Keteyian, S.J. ; Kraus, W.E.</creatorcontrib><description>Intrinsic changes in skeletal muscle are being increasingly suspected as part of the underlying cause of exercise intolerance in patients with chronic heart failure (CHF). The objective of the present study was to determine whether differences existed between CHF patients and age‐matched healthy controls in the concentration of skeletal muscle Na+‐K+–ATPase (adenosine triphosphatase), a cation pump that functions to restore Na+‐K+ gradients and protect membrane excitability. Moreover, given the potency for physical activity in altering long‐term regulation of the pump, an additional objective was to examine the role of activity level in pump expression in CHF patients. Na+‐K+–ATPase concentration (pmol/g wet wt) determined in the vastus lateralis muscle of 27 CHF males (ejection fraction, 23 ± 1.6%), using the vanadate facilitated [3H] ouabain binding technique, was not different (264 ± 10) from 10 sedentary controls (268 ± 19,P &gt; 0.05). Similarly, no differences (P &gt; 0.05) could be found between female patients (228 ± 16, n = 7) and controls (243 ± 13, n = 9). Differences between untrained control (294 ± 20, n = 7), chronically active (251 ± 20, n = 9), and trained (252 ± 16, n = 6) CHF groups in Na+‐K+ pump expression were also insignificant. This study indicates that long‐term regulation of Na+‐K+–ATPase concentration is not altered in moderate CHF patients, regardless of the history of regular activity. However, the positive correlations (P &lt; 0.05) that were observed between peak aerobic power (V̇O2 peak) and Na+‐K+–ATPase (r = 0.422) and V̇O2 peak and maximal citrate synthase activity (r = 0.404) suggests a role for the skeletal muscle in explaining exercise intolerance in CHF patients. © 2001 John Wiley &amp; Sons, Inc. Muscle Nerve 24: 69–76, 2001</description><identifier>ISSN: 0148-639X</identifier><identifier>EISSN: 1097-4598</identifier><identifier>DOI: 10.1002/1097-4598(200101)24:1&lt;69::AID-MUS8&gt;3.0.CO;2-O</identifier><identifier>PMID: 11150968</identifier><identifier>CODEN: MUNEDE</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>Binding, Competitive - drug effects ; Biological and medical sciences ; Cardiology. Vascular system ; Chronic Disease ; chronic heart failure ; Citrate (si)-Synthase - metabolism ; Digoxin - administration &amp; dosage ; Exercise - physiology ; exercise intolerance ; Exercise Tolerance - drug effects ; Exercise Tolerance - physiology ; Female ; Heart ; Heart Failure - metabolism ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Humans ; Male ; Medical sciences ; Middle Aged ; Muscle, Skeletal - chemistry ; Muscle, Skeletal - metabolism ; Oxidation-Reduction - drug effects ; peak aerobic power ; Sex Factors ; skeletal muscle ; sodium-potassium pump ; Sodium-Potassium-Exchanging ATPase - analysis ; Sodium-Potassium-Exchanging ATPase - metabolism ; Stroke Volume ; training</subject><ispartof>Muscle &amp; nerve, 2001-01, Vol.24 (1), p.69-76</ispartof><rights>Copyright © 2001 John Wiley &amp; Sons, Inc.</rights><rights>2001 INIST-CNRS</rights><rights>Copyright 2001 John Wiley &amp; Sons, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4148-90349782492eceac1a55a75be7c8c1814688382f827e1e3878eff3848af75ffe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F1097-4598%28200101%2924%3A1%3C69%3A%3AAID-MUS8%3E3.0.CO%3B2-O$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F1097-4598%28200101%2924%3A1%3C69%3A%3AAID-MUS8%3E3.0.CO%3B2-O$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,4024,27923,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=966243$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11150968$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Green, H.J.</creatorcontrib><creatorcontrib>Duscha, B.D.</creatorcontrib><creatorcontrib>Sullivan, M.J.</creatorcontrib><creatorcontrib>Keteyian, S.J.</creatorcontrib><creatorcontrib>Kraus, W.E.</creatorcontrib><title>Normal skeletal muscle Na+-K+ pump concentration in patients with chronic heart failure</title><title>Muscle &amp; nerve</title><addtitle>Muscle Nerve</addtitle><description>Intrinsic changes in skeletal muscle are being increasingly suspected as part of the underlying cause of exercise intolerance in patients with chronic heart failure (CHF). The objective of the present study was to determine whether differences existed between CHF patients and age‐matched healthy controls in the concentration of skeletal muscle Na+‐K+–ATPase (adenosine triphosphatase), a cation pump that functions to restore Na+‐K+ gradients and protect membrane excitability. Moreover, given the potency for physical activity in altering long‐term regulation of the pump, an additional objective was to examine the role of activity level in pump expression in CHF patients. Na+‐K+–ATPase concentration (pmol/g wet wt) determined in the vastus lateralis muscle of 27 CHF males (ejection fraction, 23 ± 1.6%), using the vanadate facilitated [3H] ouabain binding technique, was not different (264 ± 10) from 10 sedentary controls (268 ± 19,P &gt; 0.05). Similarly, no differences (P &gt; 0.05) could be found between female patients (228 ± 16, n = 7) and controls (243 ± 13, n = 9). Differences between untrained control (294 ± 20, n = 7), chronically active (251 ± 20, n = 9), and trained (252 ± 16, n = 6) CHF groups in Na+‐K+ pump expression were also insignificant. This study indicates that long‐term regulation of Na+‐K+–ATPase concentration is not altered in moderate CHF patients, regardless of the history of regular activity. However, the positive correlations (P &lt; 0.05) that were observed between peak aerobic power (V̇O2 peak) and Na+‐K+–ATPase (r = 0.422) and V̇O2 peak and maximal citrate synthase activity (r = 0.404) suggests a role for the skeletal muscle in explaining exercise intolerance in CHF patients. © 2001 John Wiley &amp; Sons, Inc. Muscle Nerve 24: 69–76, 2001</description><subject>Binding, Competitive - drug effects</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Chronic Disease</subject><subject>chronic heart failure</subject><subject>Citrate (si)-Synthase - metabolism</subject><subject>Digoxin - administration &amp; dosage</subject><subject>Exercise - physiology</subject><subject>exercise intolerance</subject><subject>Exercise Tolerance - drug effects</subject><subject>Exercise Tolerance - physiology</subject><subject>Female</subject><subject>Heart</subject><subject>Heart Failure - metabolism</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Muscle, Skeletal - chemistry</subject><subject>Muscle, Skeletal - metabolism</subject><subject>Oxidation-Reduction - drug effects</subject><subject>peak aerobic power</subject><subject>Sex Factors</subject><subject>skeletal muscle</subject><subject>sodium-potassium pump</subject><subject>Sodium-Potassium-Exchanging ATPase - analysis</subject><subject>Sodium-Potassium-Exchanging ATPase - metabolism</subject><subject>Stroke Volume</subject><subject>training</subject><issn>0148-639X</issn><issn>1097-4598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkF1rFDEUQAdR7Lb6F2RAEKXMmq-ZZFYRyqq1uN0Ba7d9u6Txhh07X01mqP33ZpxlffHBp9yEw8nlRFFKyZwSwt5SkstEpLl6zQihhL5hYkHfZ_licXL2MTm_vFAf-JzMl8U7lhSPotmefxzNCBUqyXh-fRAdev-TBIHK5NPogFKakjxTs-hq3bpaV7G_xQr7MNSDNxXGa32cfD2Ou6HuYtM2Bpve6b5sm7hs4i5M4cHH92W_jc3WtU1p4i1q18dWl9Xg8Fn0xOrK4_PdeRRdfv70ffklWRWnZ8uTVWLEuFxOuMilYiJnaFAbqtNUy_QGpVGGKioypbhiVjGJFLmSCq3lSihtZWot8qPo1eTtXHs3oO-hLr3BqtINtoMHSVLJiVABPJ9A41rvHVroXFlr9wCUwFgaxnIwloOpNDABFLIcIJSGsTRwILAsgEERfC92Hw83Nf74a9ulDcDLHaC90ZV1ujGl33N5ljHBA7WeqPuywof_3-kfK_25B2EyCUvf46-9ULtbyCSXKVytT2F1wb5tNptryPhv5IWxFA</recordid><startdate>200101</startdate><enddate>200101</enddate><creator>Green, H.J.</creator><creator>Duscha, B.D.</creator><creator>Sullivan, M.J.</creator><creator>Keteyian, S.J.</creator><creator>Kraus, W.E.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200101</creationdate><title>Normal skeletal muscle Na+-K+ pump concentration in patients with chronic heart failure</title><author>Green, H.J. ; Duscha, B.D. ; Sullivan, M.J. ; Keteyian, S.J. ; Kraus, W.E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4148-90349782492eceac1a55a75be7c8c1814688382f827e1e3878eff3848af75ffe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Binding, Competitive - drug effects</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Chronic Disease</topic><topic>chronic heart failure</topic><topic>Citrate (si)-Synthase - metabolism</topic><topic>Digoxin - administration &amp; dosage</topic><topic>Exercise - physiology</topic><topic>exercise intolerance</topic><topic>Exercise Tolerance - drug effects</topic><topic>Exercise Tolerance - physiology</topic><topic>Female</topic><topic>Heart</topic><topic>Heart Failure - metabolism</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Muscle, Skeletal - chemistry</topic><topic>Muscle, Skeletal - metabolism</topic><topic>Oxidation-Reduction - drug effects</topic><topic>peak aerobic power</topic><topic>Sex Factors</topic><topic>skeletal muscle</topic><topic>sodium-potassium pump</topic><topic>Sodium-Potassium-Exchanging ATPase - analysis</topic><topic>Sodium-Potassium-Exchanging ATPase - metabolism</topic><topic>Stroke Volume</topic><topic>training</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Green, H.J.</creatorcontrib><creatorcontrib>Duscha, B.D.</creatorcontrib><creatorcontrib>Sullivan, M.J.</creatorcontrib><creatorcontrib>Keteyian, S.J.</creatorcontrib><creatorcontrib>Kraus, W.E.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Muscle &amp; nerve</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Green, H.J.</au><au>Duscha, B.D.</au><au>Sullivan, M.J.</au><au>Keteyian, S.J.</au><au>Kraus, W.E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Normal skeletal muscle Na+-K+ pump concentration in patients with chronic heart failure</atitle><jtitle>Muscle &amp; nerve</jtitle><addtitle>Muscle Nerve</addtitle><date>2001-01</date><risdate>2001</risdate><volume>24</volume><issue>1</issue><spage>69</spage><epage>76</epage><pages>69-76</pages><issn>0148-639X</issn><eissn>1097-4598</eissn><coden>MUNEDE</coden><abstract>Intrinsic changes in skeletal muscle are being increasingly suspected as part of the underlying cause of exercise intolerance in patients with chronic heart failure (CHF). The objective of the present study was to determine whether differences existed between CHF patients and age‐matched healthy controls in the concentration of skeletal muscle Na+‐K+–ATPase (adenosine triphosphatase), a cation pump that functions to restore Na+‐K+ gradients and protect membrane excitability. Moreover, given the potency for physical activity in altering long‐term regulation of the pump, an additional objective was to examine the role of activity level in pump expression in CHF patients. Na+‐K+–ATPase concentration (pmol/g wet wt) determined in the vastus lateralis muscle of 27 CHF males (ejection fraction, 23 ± 1.6%), using the vanadate facilitated [3H] ouabain binding technique, was not different (264 ± 10) from 10 sedentary controls (268 ± 19,P &gt; 0.05). Similarly, no differences (P &gt; 0.05) could be found between female patients (228 ± 16, n = 7) and controls (243 ± 13, n = 9). Differences between untrained control (294 ± 20, n = 7), chronically active (251 ± 20, n = 9), and trained (252 ± 16, n = 6) CHF groups in Na+‐K+ pump expression were also insignificant. This study indicates that long‐term regulation of Na+‐K+–ATPase concentration is not altered in moderate CHF patients, regardless of the history of regular activity. However, the positive correlations (P &lt; 0.05) that were observed between peak aerobic power (V̇O2 peak) and Na+‐K+–ATPase (r = 0.422) and V̇O2 peak and maximal citrate synthase activity (r = 0.404) suggests a role for the skeletal muscle in explaining exercise intolerance in CHF patients. © 2001 John Wiley &amp; Sons, Inc. Muscle Nerve 24: 69–76, 2001</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>11150968</pmid><doi>10.1002/1097-4598(200101)24:1&lt;69::AID-MUS8&gt;3.0.CO;2-O</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0148-639X
ispartof Muscle & nerve, 2001-01, Vol.24 (1), p.69-76
issn 0148-639X
1097-4598
language eng
recordid cdi_proquest_miscellaneous_70573048
source MEDLINE; Access via Wiley Online Library
subjects Binding, Competitive - drug effects
Biological and medical sciences
Cardiology. Vascular system
Chronic Disease
chronic heart failure
Citrate (si)-Synthase - metabolism
Digoxin - administration & dosage
Exercise - physiology
exercise intolerance
Exercise Tolerance - drug effects
Exercise Tolerance - physiology
Female
Heart
Heart Failure - metabolism
Heart failure, cardiogenic pulmonary edema, cardiac enlargement
Humans
Male
Medical sciences
Middle Aged
Muscle, Skeletal - chemistry
Muscle, Skeletal - metabolism
Oxidation-Reduction - drug effects
peak aerobic power
Sex Factors
skeletal muscle
sodium-potassium pump
Sodium-Potassium-Exchanging ATPase - analysis
Sodium-Potassium-Exchanging ATPase - metabolism
Stroke Volume
training
title Normal skeletal muscle Na+-K+ pump concentration in patients with chronic heart failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T16%3A10%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Normal%20skeletal%20muscle%20Na+-K+%20pump%20concentration%20in%20patients%20with%20chronic%20heart%20failure&rft.jtitle=Muscle%20&%20nerve&rft.au=Green,%20H.J.&rft.date=2001-01&rft.volume=24&rft.issue=1&rft.spage=69&rft.epage=76&rft.pages=69-76&rft.issn=0148-639X&rft.eissn=1097-4598&rft.coden=MUNEDE&rft_id=info:doi/10.1002/1097-4598(200101)24:1%3C69::AID-MUS8%3E3.0.CO;2-O&rft_dat=%3Cproquest_cross%3E70573048%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70573048&rft_id=info:pmid/11150968&rfr_iscdi=true